美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Kyntra Bio Inc

7.06

-0.0700-0.98%

盤後：7.060.00000.00%16:10 EDT

成交量：3.25萬

成交額：23.06萬

市值：2,856.08萬

市盈率：0.16

高：7.28

開：7.23

低：7.00

收：7.13

52周最高：12.60

52周最低：4.85

股本：404.54萬

流通股本：362.37萬

量比：0.64

換手率：0.90%

股息：- -

股息率：- -

每股收益(TTM):45.37

每股收益(LYR):45.37

淨資產收益率：--

總資產收益率：-16.96%

市淨率：-0.95

市盈率(LYR):0.16

資料載入中...

總覽公司新聞資訊公告

Kyntra Bio公布FG-3246聯合恩雜魯胺治療轉移性去勢抵抗性前列腺癌的研究者發起1B/2期研究積極數據，將於2026年ASCO GU大會展示

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/KYNB/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KYNB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KYNB\",,,,,undefined,":{"symbol":"KYNB","market":"US","secType":"STK","nameCN":"Kyntra Bio Inc","latestPrice":7.06,"timestamp":1774296000000,"preClose":7.13,"halted":0,"volume":32471,"hourTrading":{"tag":"盘后","latestPrice":7.06,"preClose":7.06,"latestTime":"16:10 EDT","volume":2,"amount":14.12,"timestamp":1774296605191,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.009817671809256702,"floatShares":3623701,"shares":4045445,"eps":45.371456,"marketStatus":"未開盤","change":-0.07,"latestTime":"03-23 16:00:00 EDT","open":7.23,"high":7.28,"low":7,"amount":230620.26216,"amplitude":0.039271,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":45.371456,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1774339200000},"marketStatusCode":0,"adr":0,"listingDate":1415941200000,"exchange":"NASDAQ","adjPreClose":7.13,"preHourTrading":{"tag":"盘前","latestPrice":7.05,"preClose":7.13,"latestTime":"09:26 EDT","volume":826,"amount":5912.5801098,"timestamp":1774272396808,"change":-0.08,"changeRate":-0.01122,"amplitude":0.01122},"postHourTrading":{"tag":"盘后","latestPrice":7.06,"preClose":7.06,"latestTime":"16:10 EDT","volume":2,"amount":14.12,"timestamp":1774296605191,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.643054},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KYNB\",,,,,undefined,":{"symbol":"KYNB","floatShares":3623701,"roa":"-16.96%","roe":"--","lyrEps":45.371456,"volumeRatio":0.643054,"shares":4045445,"dividePrice":0,"high":7.28,"amplitude":0.039271,"preClose":7.13,"low":7,"week52Low":4.85,"pbRate":"-0.95","psRate":"4.43","week52High":12.6,"institutionHeld":0,"latestPrice":7.06,"eps":45.371456,"divideRate":0,"volume":32471,"delay":0,"ttmEps":45.371456,"open":7.23,"prevYearClose":8.78,"prevWeekClose":7.13,"prevMonthClose":6.93,"prevQuarterClose":8.78,"fiveDayClose":7,"twentyDayClose":8.05,"sixtyDayClose":8.43},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KYNB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-16","symbol":"KYNB","fiscalQuarterEnding":"2025/12","expectedEps":-3.89,"name":null,"time":"盤後","type":"earning","dateTimestamp":1773633600000,"reportTimeType":"post","actualEps":-3.61}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KYNB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KYNB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.5,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":2,"updateTime":1734667200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KYNB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KYNB","date":"2026-03-20","current":0.155604,"percent":0.734694,"low":0.128311,"twenty":0.133301,"median":0.147633,"eighty":0.164047,"high":0.18215,"avg":0.150059,"sd":0.015515,"marketCap":29541837},"quantilePoints":[{"date":"2026-01-09","current":0.17821,"twenty":0.178998,"median":0.18018,"eighty":0.181362,"marketCap":38431727},{"date":"2026-01-16","current":0.170144,"twenty":0.170369,"median":0.172958,"eighty":0.17821,"marketCap":36692186},{"date":"2026-01-23","current":0.168268,"twenty":0.168268,"median":0.171269,"eighty":0.17821,"marketCap":36287641},{"date":"2026-01-30","current":0.150259,"twenty":0.160389,"median":0.169206,"eighty":0.172958,"marketCap":32404014},{"date":"2026-02-06","current":0.140692,"twenty":0.153073,"median":0.163953,"eighty":0.171457,"marketCap":30340837},{"date":"2026-02-13","current":0.140317,"twenty":0.147445,"median":0.160201,"eighty":0.171269,"marketCap":30259928},{"date":"2026-02-20","current":0.14707,"twenty":0.146282,"median":0.158795,"eighty":0.170369,"marketCap":31716288},{"date":"2026-02-27","current":0.13075,"twenty":0.144894,"median":0.154199,"eighty":0.170144,"marketCap":28196751},{"date":"2026-03-06","current":0.129155,"twenty":0.137315,"median":0.150635,"eighty":0.168643,"marketCap":27852888},{"date":"2026-03-13","current":0.131688,"twenty":0.133714,"median":0.147445,"eighty":0.165191,"marketCap":28399023},{"date":"2026-03-20","current":0.161033,"twenty":0.133301,"median":0.147633,"eighty":0.164047,"marketCap":29541837}],"updateTime":1774325822650},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KYNB\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1173376495","title":"Kyntra Bio公布FG-3246聯合恩雜魯胺治療轉移性去勢抵抗性前列腺癌的研究者發起1B/2期研究積極數據，將於2026年ASCO GU大會展示","url":"https://stock-news.laohu8.com/highlight/detail?id=1173376495","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173376495?lang=zh_tw&edition=fundamental","pubTime":"2026-02-24 06:11","pubTimestamp":1771884675,"startTime":"0","endTime":"0","summary":"Kyntra Bio公司宣布，其FG-3246与恩杂鲁胺联合用药方案针对转移性去势抵抗性前列腺癌患者的临床研究取得积极进展。这项由研究者发起的1B/2期试验数据显示出显著治疗潜力，相关完整数据报告已获选将于2026年美国临床肿瘤学会泌尿生殖系统肿瘤研讨会进行正式发布。\n该研究聚焦于晚期前列腺癌治疗领域的前沿探索，通过双药联用策略旨在突破现有治疗方案瓶颈。试验结果不仅验证了联合用药的安全性特征，更展现出令人鼓舞的疗效信号，为转移性去势抵抗性前列腺癌患者提供了新的治疗希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYNB","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}]}}